PankajAroraMDFAHA, FASE

Echocardiography, Non-Invasive Cardiology, Cardiovascular Disease Genetics

Associate Professor of Medicine, Tenured Director, Cardiovascular Clinical and Translational Research Program Director, UAB Cardiovascular Genetics Clinic Program

Join to view full profile

Dr. Arora is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Arora's full profile

Already have an account?

Office
510 20th St S
# Fot
Birmingham, AL 35233
Phone+1 205-996-6630

Summary

Dr. Pankaj Arora is a cardiologist in Birmingham, AL and is affiliated with multiple hospitals in the area, including University of Alabama Hospital and Birmingham Veterans Affairs Medical Center. He received his medical degree from Kasturba Medical College Manipal and has been in practice 19 years. He specializes in echocardiography, non-invasive cardiology, and cardiovascular disease genetics and is experienced in cardiomyopathies and cardiac genetics. He has more than 100 publications and over 500 citings.

Education & Training

Kasturba Medical College ManipalClass of 2003

Certifications & Licensure

AL State Medical License 2012 - 2024
MA State Medical License 2009 - 2014
American Board of Internal Medicine Internal Medicine

Clinical Trials

GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study Start of enrollment: 2022 Apr 01
Recruiting
Not Applicable
CARBON: UAB Cardiovascular Research Biobank Start of enrollment: 2022 Jan 01
Recruiting
PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis Start of enrollment: 2022 Feb 18
Recruiting
Phase 2, Phase 3
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals Start of enrollment: 2020 Aug 15
Recruiting
Phase 2
Racial Differences in the Natriuretic Peptide Response to Glucose Challenge Start of enrollment: 2017 Mar 01
Completed
Not Applicable
Race, Natriuretic Peptides and Physiological Perturbations Start of enrollment: 2017 Apr 30
Active, not recruiting
Phase 2
The Diurnal Rhythm in Natriuretic Peptide Levels Start of enrollment: 2019 Apr 01
Completed
Not Applicable
Mechanistic Insights to Weight Loss Maintenance Through SGLT2 Inhibitors Start of enrollment: 2025 Jan 30
Not yet recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

9 citations
Cardiovascular Burden of the V142I Transthyretin Variant.
Senthil Selvaraj, Brian Claggett, Svati H Shah, Robert J Mentz, Michel G Khouri
JAMA. 2024-06-04
28 citations
Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants.
Ravi A Shah, Babken Asatryan, Ghaith Sharaf Dabbagh, Nay Aung, Mohammed Y Khanji
Circulation. 2022-07-12
21 citations
Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals.
Vibhu Parcha, Gargya Malla, Marguerite R Irvin, Nicole D Armstrong, Suzanne E Judd
JAMA. 2022-04-12

Press Mentions

Study Uncovers the Role of Polygenic Risk Scores in Hypertension ManagementSeptember 30th, 2024
Study Unveils Impact of Cardiovascular Risk Factors on Genetic Predisposition to Heart DiseaseAugust 14th, 2024
Study Reveals Impact of Cardiovascular Risk Factors on Genetic Predisposition to Heart Disease – NewsAugust 13th, 2024
Join now to see all